Ruoyi Bio
Latest round
- Angel
Last raised
- Mar 2022
Total raised
- $7.8M
Investors
- 3
About Ruoyi Bio
, Ltd, traing as Ruoyi Bio, is a biotech company that focuses on the development of macromolecular drug delivery technologies. It is a biotechnology startup incubated by ShanghaiTech University. Jia Liu, the chairman, founder, and CSO of the company, graduated from the University of Maryland, College Park, and is also a researcher at the Institute of Immunochemistry, ShanghaiTech University. Ruoyi Bio's main business is the research and development of macromolecular drug delivery technology and related products. The company has independently developed a zinc finger protein drug delivery technology platform and an insect cell-baculovirus production process platform. The core drug pipeline under development is recombinant botulinum toxin protein drugs and intracellular antibodies. The products can be used to treat tumors and infectious diseases. The company generates revenue by providing macromolecular drug delivery technology and related products.
Who invested in Ruoyi Bio
3 investors across 1 round
See all investors in Ruoyi Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Mar 28, 2022
Amount
$7.8M
Investors
Questions about Ruoyi Bio
Who invested in Ruoyi Bio?
Ruoyi Bio has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ruoyi Bio raised?
Ruoyi Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ruoyi Bio last raise money?
Ruoyi Bio's most recent round on record is a Angel, in Mar 2022.
What does Ruoyi Bio do?
, Ltd, traing as Ruoyi Bio, is a biotech company that focuses on the development of macromolecular drug delivery technologies.
Where is Ruoyi Bio headquartered?
Ruoyi Bio is headquartered in Shanghai, China.
Which VCs invest in companies like Ruoyi Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Ruoyi Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Ruoyi Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.